Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome

Aliment Pharmacol Ther. 2023 Jan;57(2):261-262. doi: 10.1111/apt.17304.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Abdominal Pain / drug therapy
  • Abdominal Pain / etiology
  • Constipation
  • Humans
  • Irritable Bowel Syndrome* / complications
  • Irritable Bowel Syndrome* / drug therapy
  • Pain Management
  • Peptides

Substances

  • linaclotide
  • Peptides